BioMarin downsizes Roctavian efforts but keeps hemophilia gene therapy for 3 markets

0

06.08.2024 17:04

Fiercepharma.com

BioMarin downsizes Roctavian efforts but keeps hemophilia gene therapy for 3 markets aliu Tue, 08/06/2024 - 10:04